Vol 1, No 3 (2009)

Mol Cell Pharmacol

Table of Contents


PUMA Kills Stem Cells to Stall Cancer? Abstract PDF
Jian Yu 112-118
Transgenic Humanized AHR Mouse Reveals Differences between Human and Mouse AHR Ligand Selectivity Abstract PDF
Colin A. Flaveny, Gary H. Perdew 119-123
Developing Antiepileptogenic Drugs for Acquired Epilepsy: Targeting the Mammalian Target of Rapamycin (mTOR) Pathway Abstract PDF
Ling-Hui Zeng, Nicholas R. Rensing, Michael Wong 124-129

Research Articles

Nucleolin Binds to the Proliferating Cell Nuclear Antigen and Inhibits Nucleotide Excision Repair Abstract PDF
Chonglin Yang, Myoung Sook Kim, Devulapalli Chakravarty, Fred E. Indig, France Carrier 130-137
Extraction, Characterization, Stability and Biological Activity of Flavonoids Isolated from Chamomile Flowers Abstract PDF
Janmejai K. Srivastava, Sanjay Gupta 138-147


RanGTPase: A Key Regulator of Nucleocytoplasmic Trafficking Abstract PDF
Ki Lui, Ying Huang 148-156
The Regulation of YY1 in Tumorigenesis and its Targeting Potential in Cancer Therapy Abstract PDF
Guangchao Sui 157-176

FDA Corner

FDA Approves New Drug Treatment for Type 2 Diabetes Abstract PDF
FDA Approves First Maintenance Drug Therapy for Advanced Lung Cancer Abstract PDF
FDA Approves Multaq to Treat Heart Rhythm Disorder Abstract PDF
FDA Approves Drug for Treatment of Aggressive Brain Cancer Abstract PDF

LumiText Publishing, P.O. Box 774, Ellicott City, MD 21041 

Copyright © 2008 LumiText Publishing. All rights reserved.